Skip to main content

Panera Takes its Meal of Responsibility Back to the Drawing Board

Back in April 2013 I wrote about Panera Bread Company’s groundbreaking Meal of Responsibility, a nutritious bowl of turkey chili with 850 calories that invited people to pay for it what they could afford. Last week the company reported that they’ve pulled the menu item and are retooling it.

At the time I wrote
“Here’s my problem: helping out can be very intoxicating, especially when you’re good at it, as Panera is. But as I often say in this space, generous people are no good to causes if they give until they’re broke. Cause marketers need sponsors that are cash cows. That is, companies that have a sustainable business model that can be ‘milked’ regularly.

Before Panera, everybody’s poster-child for progressive corporate social responsibility was Timberland, the shoe and apparel company.

But after riding high through much of the 1980s and 1990s, Timberland’s product line grew a little stale in the double-aughts. Growth stalled. Facing rising material costs and lower profit margins, Timberland sold itself to VF in 2011 for $2 billion.    

Cause marketing and corporate social responsibility provide a kind of insurance effect to companies that practice it. But it’s not the kind of insurance that writes companies a check after a bad year or two.”
The idea of the Meal of Responsibility was that the poor could pay little and the more affluent could pay more. It was an extension of the five Panera Cares Cafes that have a pay-what-you-can model across the entire menu. The suggested price was $6. The menu item was available only at 48 Panera stores in the St. Louis area, where the company is headquartered.

During the test phase Panera served 15,000 of the meals, but few needy people participated because the St. Louis Panera locations are mainly in middle-class and affluent areas.

Moreover, says Ron Shaich, Panera’s founder, the marketing wasn’t up to snuff. “We were very capable of raising the level of awareness about food security in short spurts,” Shaich told the Associated Press, but employees stopped explaining the concept to customers as the in-store marketing changed. “It seemed to fall into the background,” Shaich said. “We decided the best thing to do was pull it and retool it.”

The Meal of Responsibility will return to Panera in the winter as a seasonal offering.

I think there’s a lesson to be learned here, namely the power of testing your cause marketing ideas with actual customers in real-life situations to see how they…and you…respond. The tech industry calls it “validated learning,” a phrase coined by Eric Ries, the author of the book “The Lean Startup.”

Panera didn’t fail with the Meal of Responsibility, at least not yet.

Comments

Popular posts from this blog

Pimping for Constant Contact

OK, not pimping really. More like a gentle noodge to nonprofits and the companies that love them that it’s time to start email marketing.

I was invited to a local presentation on email marketing from Constant Contact, the Waltham, Massachusetts email marketing outfit whose target market is small businesses and nonprofits.

They offer a cause-related marketing campaign called Care4Kids meant to benefit children’s causes. Constant Contact customers are invited to nominate worthy 501(c)(3) children’s charities to receive a free account along with the training to create an effective email campaign.

Non children’s charities are probably still eligible for charity discounts. If you’re outside the United States you might be able to induce Constant Contact to consider your cause. Alternately, you could suggest a similar program to email marketing vendors in your home country.

It goes without saying… I hope… that every nonprofit needs an email marketing component. Email marketing is a good deal lik…

Batting Your Eyelashes at Prescription Drug Cause Marketing

I’m a little chary about making sweeping pronouncements, but I believe I've just seen the first cause marketing promotion in the U.S. involving a prescription drug.

The drug is from Allergan and it’s called Latisse, “the first and only FDA-approved prescription treatment for inadequate or not enough eyelashes.” The medical name for this condition is hypotrichosis.

Latisse is lifestyle drug the way Viagra or Propecia are. That is, no one’s going to die (except, perhaps, of embarrassment) if their erectile dysfunction or male pattern baldness or thin eyelashes go untreated.

Which means the positioning for a product like Latisse is a little tricky. Allergan could have gone with the sexy route as with Viagra or Cialis and showed lovely women batting their new longer, thicker, darker eyelashes. But I’ll bet that approach didn’t test well with women.

(I’m reminded of a joke about the Cialis ads from a comedian whose name I can’t recall. He said, “Hey if my erection lasts longer than 3 hours…

The Alden Keene Cause Marketing Stock Index Dramatically Outperforms Other Indices

There are stock indexes galore; the Dow, S&P 500, the NASDAQ Composite, the Wilshire 5000, the FTSE, and hundreds more. But how would an index of the stocks of companies that do a meaningful amount of cause marketing perform compared to those well-known indexes? Pretty well, as it turns out.

I first floated the idea of a stock index that would track companies that do cause marketing back in 2009. I tried to figure out Yahoo Pipes so that I could put the feed right into this blog. But alas sometimes the geek gene does fall pretty far from the tree.

So I talked to programmers to see if I could find someone who could do the same, but it was always more than I was willing to pay.

Finally, last week I hired a MBA student to do it all in a spreadsheet, and what do you know but that over the last 15 years a basket of 25 cause marketing stocks dramatically outperforms the Dow, the S&P 500, the NASDAQ Composite, and the Wilshire 5000.

The index, which I call the Alden Keene Cause Market…